Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body.
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, researchers at Stanford Medicine have found. Manipulating this pathway ...
Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, offering a unique potential to selectively target malignant cells while sparing normal tissues.
The COVID-19 pandemic gave us tremendous perspective on how wildly symptoms and outcomes can vary between patients ...
The idea of turning back the clock on the immune system has moved from science fiction to a concrete experimental strategy. A ...